The analysis depicted significant differences of SV2B levels between astrocytomas, IDH-wildtype diffuse astrocytic tumours, and oligodendrogliomas when compared to glioblastomas, the latter expressing higher protein abundance within patient samples. The gene discussed is SV2B; the disease is oligodendroglioma.